PAVM - PAVmed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

PAVM is currently covered by 1 analysts

PAVmed's activity chart (see below) currently has 25 price targets and 27 ratings on display. The stock rating distribution of PAVM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 23.96% of the time, taking 131 days on average.

Highest price target for PAVM is $11, Lowest price target is $5.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 27-Aug-2026. First documented stock forecast 22-Feb-2021.

Best performing analysts who are covering PAVM - PAVmed:

Anthony Vendetti Edward Woo Frank Takkinen Ross Osborn

Currently out of the existing stock ratings of PAVM, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Mar-2021

2 months 26 days ago
(27-Aug-2026)

5/8 (62.5%)

$6.33 (58.77%)

38

Hold Since 18-Aug-2023

3 years 3 months 4 days ago
(18-Aug-2023)

0/2 (0%)

$1691.47 (302.84%)

Buy Since 23-Feb-2021

$675

$1350

3 years 8 months 7 days ago
(15-Mar-2023)

2/6 (33.33%)

$508.22 (304.72%)

486

Buy Since 22-Feb-2021

$2250

3 years 10 months 4 days ago
(18-Jan-2023)

0/2 (0%)

$1718.63 (323.43%)

Show more analysts

Please expand the browser size to see the chart

What is PAVM (PAVmed) average time for price targets to be met?

On average it took 131 days for the stock forecasts to be reached, with an average price target met ratio of 23.96%.

Which analyst most recently updated their price target on PAVM (PAVmed)?

Edward Woo

Which analyst has the lowest performance score on PAVM (PAVmed) with a proven track record?

ROSS OSBORN

Which analyst has the most public recommendations on PAVM (PAVmed)?

Edward Woo works at ASCENDIANT and has 5 price targets and 5 ratings on PAVM

Which analyst is the currently most bullish on PAVM (PAVmed)?

Anthony Vendetti with the highest potential upside of $673.86

Which analyst is the currently most reserved on PAVM (PAVmed)?

Ross Osborn with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?